Literature DB >> 7214321

Transport and binding of hematoporphyrin derivative and related porphyrins by murine leukemia L1210 cells.

D Kessel.   

Abstract

A hematoporphyrin derivative (abbreviated in the literature as "HPD") has been used successfully for phototherapy of tumors in the clinic. The chemical nature of HPD, a complex mixture of porphyrins, is not fully understood. This study was designed to provide an explanation for the superior tumor-localizing ability of HPD. Chromatographic behavior, hydrophobicity, transport, binding, and photosensitizing capacity of different porphyrins were examined and compared. Biological studies were carried out using murine leukemia L1210 cells in vitro. The initial rate of porphyrin uptake was a function of drug hydrophobicity. The most hydrophobic components of HPD were therefore the most potent photosensitizers when irradiation followed a 10-min porphyrin-loading incubation. But these and other hydrophobic porphyrins were readily washed from cells by medium containing serum. Hydrophilic components of HPD were gradually accumulated by L1210 cells via a mode of binding not readily dissociated by washing and appear to be responsible for the preferential affinity of this product for neoplastic cells. A portion of the tightly bound porphyrin could not be dissociated by sodium dodecyl sulfate:polyacrylamide gel electrophoresis but remained bound to a low-molecular weight membrane component.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7214321

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Response of human endometrium and ovarian carcinoma cell-lines to photodynamic therapy.

Authors:  G H Raab; A F Schneider; W Eiermann; H Gottschalk-Deponte; R Baumgartner; W Beyer
Journal:  Arch Gynecol Obstet       Date:  1990       Impact factor: 2.344

2. 

Authors:  C S Betz; A Leunig
Journal:  HNO       Date:  2004-02       Impact factor: 1.284

3.  Enhanced photodynamic efficacy and efficient delivery of Rose Bengal using nanostructured poly(amidoamine) dendrimers: potential application in photodynamic therapy of cancer.

Authors:  Krishnamoorthy Karthikeyan; Anish Babu; Sang-Jae Kim; Ramachandran Murugesan; Kadarkaraithangam Jeyasubramanian
Journal:  Cancer Nanotechnol       Date:  2011-08-13

4.  Assessment of effect of photosensitizers on cytotoxicity of photodynamic therapy in human breast cancer cell cultures.

Authors:  O R Koechli; G N Schaer; V Schenk; U Haller; H Walt
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

5.  Fluorimetric studies on the dimerization equilibrium of protoporphyrin IX and its haemato derivative.

Authors:  R Margalit; N Shaklai; S Cohen
Journal:  Biochem J       Date:  1983-02-01       Impact factor: 3.857

6.  Haematoporphyrin and OO'-diacetylhaematoporphyrin binding by serum and cellular proteins. Implications for the clearance of these photochemotherapeutic agents by cells.

Authors:  A Smith; T Neuschatz
Journal:  Biochem J       Date:  1983-08-15       Impact factor: 3.857

7.  Thermodynamics of porphyrin dimerization in aqueous solutions.

Authors:  R Margalit; M Rotenberg
Journal:  Biochem J       Date:  1984-04-15       Impact factor: 3.857

8.  Deuteroporphyrin-albumin binding equilibrium. The effects of porphyrin self-aggregation studied for the human and the bovine proteins.

Authors:  M Rotenberg; R Margalit
Journal:  Biochem J       Date:  1985-07-01       Impact factor: 3.857

9.  Evaluation of tumour and tissue distribution of porphyrins for use in photodynamic therapy.

Authors:  K W Woodburn; S Stylli; J S Hill; A H Kaye; J A Reiss; D R Phillips
Journal:  Br J Cancer       Date:  1992-03       Impact factor: 7.640

10.  Relationship between changes in antigen expression and protein synthesis in human melanoma cells after hyperthermia and photodynamic treatment.

Authors:  C L Davies; T Ranheim; Z Malik; E K Rofstad; J Moan; T Lindmo
Journal:  Br J Cancer       Date:  1988-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.